Evidence map›Paper›PMID 42621423›Full record

ArticleBlood vessels, thrombosis & hemostasis2026

New insights into flavonoid binding to the thromboxane A

Chao Han, Xiang Chu, Pengxuan Ren, Payal Lonkar, Arthur Bassot, Erika Cosset, Bin Xu, Elmina Mammadova-Bach, Thomas Gudermann, Attila Braun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood vessels, thrombosis & hemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chao HanWalther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University Munich, Munich, Germany.
Xiang ChuWalther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University Munich, Munich, Germany.
Pengxuan RenSchool of Life Science and Technology, and Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
Payal LonkarWalther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University Munich, Munich, Germany.
Arthur BassotDepartment of CITI, Team GLIMMER of Light, Cancer Research Centre of Lyon, INSERM U1052, CNRS UMR 5286, Institut Convergence Plascan, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.
Erika CossetDepartment of CITI, Team GLIMMER of Light, Cancer Research Centre of Lyon, INSERM U1052, CNRS UMR 5286, Institut Convergence Plascan, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.
Bin XuDepartment of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Elmina Mammadova-BachWalther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University Munich, Munich, Germany.
Thomas GudermannWalther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University Munich, Munich, Germany.
Attila BraunWalther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspirin treatment irreversibly inhibits cyclooxygenase activity, blocking thromboxane A

Identifiers

PMID42621423
PMCPMC13488055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.